US DOJ initiates probe into collusion and price fixing by global Generic producers active in the US market. Just to clarify, Indian Pharma controls 40 per cent of the US generic market, and one drugs go off patent price falls for Generics are as much as 90 per cent. The first to file ANDA players get a 180 day exclusivity window to price their products roughly at very low levels before it becomes a free for all. However, if all generic players combine then generic drugs may continue to retain price at 10 per cent of patented drugs. But severe penalties, combined with a Hillary win can severely dent Jubilant Life, Sun, Dr. Reddy, Aurobindo and earnings models of many pharma players from India.
-- You received this message because you are subscribed to the Google Groups "LONGTERMINVESTORSRESEARCH" group.
To unsubscribe from this group and stop receiving emails from it, send an email to longterminvestorsresearch+unsubscribe@googlegroups.com.
Visit this group at https://groups.google.com/group/longterminvestorsresearch.
For more options, visit https://groups.google.com/d/optout.
No comments:
Post a Comment